Leuprolide Acetate is a synthetic analogue of gonadotropin-releasing hormone (GnRH) used to regulate reproductive hormone production. It initially stimulates the pituitary GnRH receptors and, with continuous administration, produces downregulation of GnRH receptors, resulting in suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
Leuprolide Acetate is used in pharmaceutical formulations for conditions including prostate cancer, endometriosis, uterine fibroids and central precocious puberty, depending on the approved formulation and indication.
Leuprolide Acetate is a specialized synthetic peptide pharmaceutical API requiring controlled peptide synthesis, purification and extensive analytical characterization.
Important quality attributes include identity, peptide purity, assay, related peptides, amino-acid composition, water content, residual solvents, elemental impurities and stability.
CAS Number: 74381-53-6
Molecular Formula: C59H84N16O12·C2H4O2
Molecular Weight: 1209.40 g/mol
Drug Class: Hormonal Agent
Pharmacological Class: GnRH Agonist
Therapeutic Class: Gonadotropin-Releasing Hormone Analogue
Therapeutic Area: Oncology / Endocrinology / Women's Health
Leuprolide Acetate acts as a potent GnRH receptor agonist.
Initially, it stimulates the pituitary gland and increases secretion of LH and FSH. With continuous exposure, persistent GnRH receptor stimulation causes receptor desensitization and downregulation.
This ultimately leads to:
Leuprolide Acetate is used in approved formulations for:
The clinical indication and dosing schedule depend on the specific formulation and applicable regulatory labeling.
Leuprolide is a synthetic nonapeptide GnRH analogue with greater resistance to enzymatic degradation than endogenous GnRH.
Its prolonged pharmacological effect allows it to be formulated for different administration schedules, including depot formulations.
Typical peptide API manufacturing may involve:
Leuprolide Acetate API quality evaluation may include:
Leuprolide Acetate should be stored in a tightly closed container under controlled pharmaceutical storage conditions, protected from excessive heat, moisture and direct light. Final storage conditions should be established according to validated stability data.
Leuprolide Acetate is relevant to research involving:
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 95.0% – 105.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 5.0% |
| Water Content | NMT 5.0% |